Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dawn Bestow"'
Autor:
Kenneth R. Watterson, Dawn Bestow, Jennifer Gallagher, D. Lee Hamilton, Fiona B. Ashford, Paul J. Meakin, Michael L.J. Ashford
Publikováno v:
Neurosignals, Vol 21, Iss 1-2, Pp 28-41 (2012)
Activation of mammalian target of rapamycin 1 (mTORC1) by nutrients, insulin and leptin leads to appetite suppression (anorexia). Contrastingly, increased AMP-activated protein kinase (AMPK) activity by ghrelin promotes appetite (orexia). However, th
Externí odkaz:
https://doaj.org/article/1e8e1898b1364d0e9499449a65c5fd65
Autor:
Dawn Bestow, Jennifer E. Gallagher, Kenneth R. Watterson, David L. Hamilton, Paul J. Meakin, Fiona B. Ashford, Michael L.J. Ashford
Publikováno v:
Neuro-Signals
Neurosignals, Vol 21, Iss 1-2, Pp 28-41 (2012)
Neurosignals, Vol 21, Iss 1-2, Pp 28-41 (2012)
Activation of mammalian target of rapamycin 1 (mTORC1) by nutrients, insulin and leptin leads to appetite suppression (anorexia). Contrastingly, increased AMP-activated protein kinase (AMPK) activity by ghrelin promotes appetite (orexia). However, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21b30d24361730b3a54884444fc8b15e
https://doi.org/10.1159/000334144
https://doi.org/10.1159/000334144
Autor:
D Lee, Hamilton, John A, Findlay, Gemma, Montagut, Paul J, Meakin, Dawn, Bestow, Susan M, Jalicy, Michael L J, Ashford
Publikováno v:
Diabetologia
Aims/hypothesis Impaired glucose uptake in skeletal muscle is an important contributor to glucose intolerance in type 2 diabetes. The aspartate protease, beta-site APP-cleaving enzyme 1 (BACE1), a critical regulator of amyloid precursor protein (APP)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fe592de321ba93e4e6eb6f2f8a31d257
https://pubmed.ncbi.nlm.nih.gov/24849570
https://pubmed.ncbi.nlm.nih.gov/24849570